Peter Fuller

Steroid Receptor Biology Laboratory, Prince Henry's Institute of Medical Research, Australia

Peter Fuller is the Head of Endocrine Genetics at Prince Henry's Institute of Medical Research. His other appointments include NHMRC Senior Principal Research Fellow, Professorial Fellow of Monash University and Head of the Endocrinology Unit, Southern Health.

Professor Fuller’s main research interests are endocrine genetics, ovarian cancer and cardiovascular disease. His current research projects include the molecular pathogenesis of granulosa cell tumours of the ovary and understanding the molecular mechanisms of action of aldosterone and the mineralocorticoid receptor.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Diabetes & Endocrinology > Adrenal Cortex (since 20 April 2007)

Links

http://www.phimr.monash.edu.au/endo_genetics/staff.htm

All recent recommendations

• 9.0
  The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development.
  Recommended by Peter Fuller
  
• 6.5
  Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
  Recommended by Peter Ebeling with Claudia Gagnon, Peter Fuller, Caroline Silve
  
• 3.0
  A GPR54-activating mutation in a patient with central precocious puberty.
  Recommended by Peter Fuller
  
• 3.0
  A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels.
  Recommended by Peter Fuller
  
• 3.0
  RbAp48 is a target of nuclear factor-kappaB activity in thyroid cancer.
  Recommended by Peter Fuller
  
• 3.0
  Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.
  Recommended by Peter Fuller
  
• 3.0
  An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
  Recommended by Peter Fuller